Martin SA - Search Results

1

Mismatch repair deficient colorectal cancer in the era of personalized treatment.

Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A. Hewish M, et al. Among authors: martin sa. Nat Rev Clin Oncol. 2010 Apr;7(4):197-208. doi: 10.1038/nrclinonc.2010.18. Epub 2010 Feb 23. Nat Rev Clin Oncol. 2010. PMID: 20177404 Review.

2

DNA repair deficiency as a therapeutic target in cancer.

Martin SA, Lord CJ, Ashworth A. Martin SA, et al. Curr Opin Genet Dev. 2008 Feb;18(1):80-6. doi: 10.1016/j.gde.2008.01.016. Epub 2008 Mar 14. Curr Opin Genet Dev. 2008. PMID: 18343102 Review.

3

RNA interference screening demystified.

Lord CJ, Martin SA, Ashworth A. Lord CJ, et al. Among authors: martin sa. J Clin Pathol. 2009 Mar;62(3):195-200. doi: 10.1136/jcp.2008.058735. Epub 2009 Jan 6. J Clin Pathol. 2009. PMID: 19126568 Free PMC article.

4

Genomic instability and the selection of treatments for cancer.

Martin SA, Hewish M, Lord CJ, Ashworth A. Martin SA, et al. J Pathol. 2010 Jan;220(2):281-9. doi: 10.1002/path.2631. J Pathol. 2010. PMID: 19890832 Review.

5

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors.

Mendes-Pereira AM, Martin SA, Brough R, McCarthy A, Taylor JR, Kim JS, Waldman T, Lord CJ, Ashworth A. Mendes-Pereira AM, et al. Among authors: martin sa. EMBO Mol Med. 2009 Sep;1(6-7):315-22. doi: 10.1002/emmm.200900041. EMBO Mol Med. 2009. PMID: 20049735 Free PMC article.

6

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2.

Martin SA, McCarthy A, Barber LJ, Burgess DJ, Parry S, Lord CJ, Ashworth A. Martin SA, et al. EMBO Mol Med. 2009 Sep;1(6-7):323-37. doi: 10.1002/emmm.200900040. EMBO Mol Med. 2009. PMID: 20049736 Free PMC article.

7

DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.

Martin SA, McCabe N, Mullarkey M, Cummins R, Burgess DJ, Nakabeppu Y, Oka S, Kay E, Lord CJ, Ashworth A. Martin SA, et al. Cancer Cell. 2010 Mar 16;17(3):235-48. doi: 10.1016/j.ccr.2009.12.046. Cancer Cell. 2010. PMID: 20227038 Free PMC article.

8

Therapeutic targeting of the DNA mismatch repair pathway.

Martin SA, Lord CJ, Ashworth A. Martin SA, et al. Clin Cancer Res. 2010 Nov 1;16(21):5107-13. doi: 10.1158/1078-0432.CCR-10-0821. Epub 2010 Sep 7. Clin Cancer Res. 2010. PMID: 20823149 Review.

9

Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers.

Martin SA, Hewish M, Sims D, Lord CJ, Ashworth A. Martin SA, et al. Cancer Res. 2011 Mar 1;71(5):1836-48. doi: 10.1158/0008-5472.CAN-10-2836. Epub 2011 Jan 17. Cancer Res. 2011. PMID: 21242281 Free article.

10

Oxidative stress and the DNA mismatch repair pathway.

Brierley DJ, Martin SA. Brierley DJ, et al. Among authors: martin sa. Antioxid Redox Signal. 2013 Jun 20;18(18):2420-8. doi: 10.1089/ars.2012.4994. Epub 2012 Dec 26. Antioxid Redox Signal. 2013. PMID: 23121537 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters